Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Cash & Equivalents (2016 - 2025)

Proto Labs (PRLB) has disclosed Cash & Equivalents for 15 consecutive years, with $110.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 24.42% to $110.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $110.8 million through Dec 2025, up 24.42% year-over-year, with the annual reading at $110.8 million for FY2025, 24.42% up from the prior year.
  • Cash & Equivalents hit $110.8 million in Q4 2025 for Proto Labs, up from $104.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $110.8 million in Q4 2025 to a low of $41.9 million in Q2 2021.
  • Historically, Cash & Equivalents has averaged $73.9 million across 5 years, with a median of $74.6 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: plummeted 59.58% in 2021 and later surged 49.56% in 2024.
  • Year by year, Cash & Equivalents stood at $65.9 million in 2021, then decreased by 14.21% to $56.6 million in 2022, then soared by 48.15% to $83.8 million in 2023, then rose by 6.3% to $89.1 million in 2024, then rose by 24.42% to $110.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for PRLB at $110.8 million in Q4 2025, $104.4 million in Q3 2025, and $90.4 million in Q2 2025.